ARKG Holdings of Ginkgo Bioworks (DNA) - Updated Daily

GenomicsSynthetic Biology

Shares HeldWeight In Fund

Trades of DNA Made In ARKG

Why do the number of shares of a company held in an ARK ETF go up or down even when no trades are reported?

Date	Direction	Shares	Fund Weight	Fund

January 5, 2023	BUY	1.163m	0.0921%	ARKG
December 29, 2022	BUY	60.879k	0.0055%	ARKG
December 22, 2022	BUY	1.979k	0.0002%	ARKG
December 20, 2022	BUY	898.783k	0.0752%	ARKG
December 16, 2022	BUY	13.934k	0.0012%	ARKG

Statistics

Institutional Ownership Trends

News That Matters

Description
Ginkgo Bioworks is building a platform to enable customers to program cells as easily as they can program computers. The company's cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
Website
www.ginkgobioworks.com

March 30, 2022

December 5, 2021

October 2, 2021

August 5, 2021